FinTechFunding

Race Oncology: Reports $1.8m in cash outflows

Race Oncology Reports $1.8m in cash outflows

  • Race Oncology (RAC) reports $1.8 million in cash outflows for the quarter, an increase from the $931,000 in outflows recorded in the previous quarter
  • The company spent $890,000 during the period for research and development
  • RAC’s focus is Zantrene, a small molecule anti-cancer drug in which the company announced numerous achievements for over the quarter
  • At the end of the period, the company had $37.1 million in cash and cash equivalents
  • Shares closed 2.81 per cent higher today at $2.93 each
Previous article
Tink: Launches “Income Check” in the UK to simplify income verification
Next article
White Cliff Minerals: Completes Cracker Jack drilling
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Regulators Strengthen Global Crackdown on Finfluencers

A new collaborative approach targets financial influencers amid rising concerns. Highlights: Financial regulators unite to control finfluencers' market impact.Concerns...
FinTech

ECB Strengthens Digital Euro Rollout with Standard Setter Agreements

New collaborations aim to facilitate the digital euro's global integration. Highlights: ECB partners with key global standard setters.Agreements aim...
FinTech

CreditNature Strengthens Nature Restoration Funding Through Everyday Transactions

New partnership enables businesses to support environmental initiatives seamlessly. Highlights: CreditNature teams up with Stabiliti for eco-friendly funding.Businesses can...
FinTech

FedNow Strengthens Instant Payments Security with New API Tool

New API tool enhances security for immediate digital transactions in the U.S. Highlights: FedNow introduces a new API tool...